Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Express Scripts
McKesson
Moodys
Johnson and Johnson

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Hydrochlorothiazide; lisinopril - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; lisinopril and what is the scope of patent protection?

Hydrochlorothiazide; lisinopril is the generic ingredient in three branded drugs marketed by Aurobindo, Corepharma, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, Watson Labs, Merck, and Alvogen, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; lisinopril. Thirty-two suppliers are listed for this compound.

Summary for hydrochlorothiazide; lisinopril
Recent Clinical Trials for hydrochlorothiazide; lisinopril

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
IPCA Laboratories Ltd.Phase 1
Scripps Translational Science InstituteN/A
William Beaumont HospitalsPhase 4

See all hydrochlorothiazide; lisinopril clinical trials

Pharmacology for hydrochlorothiazide; lisinopril

US Patents and Regulatory Information for hydrochlorothiazide; lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-003 Nov 18, 1993 AB RX Yes No   Start Trial   Start Trial   Start Trial
Watson Labs LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076194-003 Jul 1, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Alvogen ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-002 Jul 20, 1989 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Heritage Pharma LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075776-002 Jul 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Teva LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075869-002 Jul 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Lupin LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 077912-003 Sep 27, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Heritage Pharma LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075776-001 Jul 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for hydrochlorothiazide; lisinopril

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Express Scripts
McKesson
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.